Latest filing published 03 Sept 2024 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €119k.
Thomas Appio discloses dealings in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) to SEDI. We count 40 filings; the first trade dates from 20 August 2018 and the latest from 30 August 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 3 September 2024, the filings show an option exercise worth €119k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Filings reach the SEDI feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 40 declarations